Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study. J of Skin. 2018;2(S1):S53. doi:10.25251/skin.2.supp.53